Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents

被引：2
作者：
Cook, G. [1 ]
机构：
[1] Univ Leeds, Dept Haematol, Transplant Immunol Grp, Sect Expt Haematol,Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷 / 10期
关键词：
HIGH-DOSE MELPHALAN; BORTEZOMIB; DEXAMETHASONE; THERAPY; PHASE-2; RELAPSE; TRIAL;
D O I：
10.1038/bmt.2015.175
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 11 条
[1]   Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation [J].
Bayraktar, Ulas D. ;
Bashir, Qaiser ;
Qazilbash, Muzaffar ;
Champlin, Richard E. ;
Ciurea, Stefan O. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) :344-356
[2]   Bortezomib, lenalidomide and dexamethasone (VRD) combination as salvage therapy in refractory angioimmunoblastic T cell lymphoma [J].
Chaoui, Driss ;
Bouallegue, Sonia ;
Arakelyan, Nina ;
Genet, Philippe ;
Aljijakli, Ahmad ;
Sutton, Laurent .
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (05) :750-752
[3]   High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial [J].
Cook, Gordon ;
Williams, Cathy ;
Brown, Julia M. ;
Cairns, David A. ;
Cavenagh, Jamie ;
Snowden, John A. ;
Ashcroft, A. John ;
Fletcher, Marie ;
Parrish, Chris ;
Yong, Kwee ;
Cavet, Jim ;
Hunter, Hanna ;
Bird, Jenny M. ;
Chalmers, Anna ;
O'Connor, Sheila ;
Drayson, Mark T. ;
Morris, Treen C. M. .
LANCET ONCOLOGY, 2014, 15 (08) :874-885
[4]   Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation [J].
Garderet, Laurent ;
Iacobelli, Simona ;
Moreau, Philippe ;
Dib, Mamoun ;
Lafon, Ingrid ;
Niederwieser, Dietger ;
Masszi, Tamas ;
Fontan, Jean ;
Michallet, Mauricette ;
Gratwohl, Alois ;
Milone, Giuseppe ;
Doyen, Chantal ;
Pegourie, Brigitte ;
Hajek, Roman ;
Casassus, Philippe ;
Kolb, Brigitte ;
Chaleteix, Carine ;
Hertenstein, Bernd ;
Onida, Francesco ;
Ludwig, Heinz ;
Ketterer, Nicolas ;
Koenecke, Christian ;
van Os, Marleen ;
Mohty, Mohamad ;
Cakana, Andrew ;
Gorin, Norbert Claude ;
de Witte, Theo ;
Harousseau, Jean Luc ;
Morris, Curly ;
Gahrton, Gosta .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) :2475-2482
[5]   Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial [J].
Gimsing, P. ;
Hjertner, O. ;
Abildgaard, N. ;
Andersen, N. F. ;
Dahl, T. G. ;
Gregersen, H. ;
Klausen, T. W. ;
Mellqvist, U-H ;
Linder, O. ;
Lindas, R. ;
Clausen, N. Toffner ;
Lenhoff, S. .
BONE MARROW TRANSPLANTATION, 2015, 50 (10) :1306-1311
[6]   A Phase I/II Trial Combining High-Dose Melphalan and Autologous Transplant with Bortezomib for Multiple Myeloma: A Dose- and Schedule-Finding Study [J].
Lonial, Sagar ;
Kaufman, Jonathan ;
Tighiouart, Mourad ;
Nooka, Ajay ;
Langston, Amelia A. ;
Heffner, Leonard T. ;
Torre, Claire ;
McMillan, Stephanie ;
Renfroe, Heather ;
Harvey, R. Donald ;
Lechowicz, Mary J. ;
Khoury, H. Jean ;
Flowers, Christopher R. ;
Waller, Edmund K. .
CLINICAL CANCER RESEARCH, 2010, 16 (20) :5079-5086
[7]  
MCELWAIN TJ, 1983, LANCET, V2, P822
[8]   The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma [J].
Min, Chang-Ki ;
Lee, Sung-Eun ;
Yahng, Seung-Ah ;
Cho, Byung-Sik ;
Eom, Ki-Seong ;
Kim, Yoo-Jin ;
Kim, Hee-Je ;
Lee, Seok ;
Cho, Seok-Goo ;
Kim, Dong-Wook ;
Lee, Jong-Wook ;
Min, Woo-Sung ;
Park, Chong-Won .
BLOOD RESEARCH, 2013, 48 (03) :198-205
[9]   Re-transplantation after bortezomib-based therapy [J].
Morris, Curly ;
Cook, Gordon ;
Streetly, Matthew ;
Kettle, Paul ;
Drake, Mary ;
Quinn, Michael ;
Cavet, Jim ;
Tighe, Jane ;
Kazmi, Majit ;
Ashcroft, John ;
Cook, Mark ;
Snowden, John ;
Olujohungbe, Ade ;
Marshall, Scott ;
Conn, Jane ;
Oakervee, Heather ;
Popat, Rakesh ;
Cavenagh, Jamie .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (05) :666-668
[10]   Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors [J].
Neri, Paola ;
Ren, Li ;
Gratton, Kathy ;
Stebner, Erin ;
Johnson, Jordan ;
Klimowicz, Alexander ;
Duggan, Peter ;
Tassone, Pierfrancesco ;
Mansoor, Adnan ;
Stewart, Douglas A. ;
Lonial, Sagar ;
Boise, Lawrence H. ;
Bahlis, Nizar J. .
BLOOD, 2011, 118 (24) :6368-6379
12